vs
OHIO VALLEY BANC CORP（OVBC）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
OHIO VALLEY BANC CORP的季度营收约是Protalix BioTherapeutics, Inc.的1.8倍（$16.2M vs $9.1M），OHIO VALLEY BANC CORP净利率更高（24.4% vs -60.3%，领先84.7%），OHIO VALLEY BANC CORP同比增速更快（-4.6% vs -49.9%），OHIO VALLEY BANC CORP自由现金流更多（$17.0M vs $1.6M），过去两年OHIO VALLEY BANC CORP的营收复合增速更高（4.3% vs -6.7%）
俄亥俄谷银行公司旗下的亚利桑那 Valley 国民银行总部位于亚利桑那州凤凰城，成立于1900年，1992年被第一银行收购。该银行是20世纪亚利桑那州顶尖的金融机构之一，在被收购时是该州最后一家大型独立银行。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
OVBC vs PLX — 直观对比
营收规模更大
OVBC
是对方的1.8倍
$9.1M
营收增速更快
OVBC
高出45.3%
-49.9%
净利率更高
OVBC
高出84.7%
-60.3%
自由现金流更多
OVBC
多$15.4M
$1.6M
两年增速更快
OVBC
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.2M | $9.1M |
| 净利润 | $4.0M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | 30.7% | -51.1% |
| 净利率 | 24.4% | -60.3% |
| 营收同比 | -4.6% | -49.9% |
| 净利润同比 | 57.3% | -184.8% |
| 每股收益（稀释后） | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OVBCPLX
| Q4 25 | $16.2M | $9.1M | ||
| Q3 25 | $16.3M | $17.9M | ||
| Q2 25 | $17.4M | $15.7M | ||
| Q1 25 | $16.8M | $10.1M | ||
| Q4 24 | $17.0M | $18.2M | ||
| Q3 24 | $15.4M | $18.0M | ||
| Q2 24 | $14.7M | $13.5M | ||
| Q1 24 | $14.9M | — |
净利润OVBCPLX
| Q4 25 | $4.0M | $-5.5M | ||
| Q3 25 | $3.0M | $2.4M | ||
| Q2 25 | $4.2M | $164.0K | ||
| Q1 25 | $4.4M | $-3.6M | ||
| Q4 24 | $2.5M | $6.5M | ||
| Q3 24 | $2.7M | $3.2M | ||
| Q2 24 | $3.0M | $-2.2M | ||
| Q1 24 | $2.8M | — |
毛利率OVBCPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率OVBCPLX
| Q4 25 | 30.7% | -51.1% | ||
| Q3 25 | 22.9% | 11.9% | ||
| Q2 25 | 29.8% | 7.5% | ||
| Q1 25 | 33.1% | -41.0% | ||
| Q4 24 | 18.1% | 39.6% | ||
| Q3 24 | 21.3% | 22.2% | ||
| Q2 24 | 24.7% | -18.0% | ||
| Q1 24 | 22.8% | — |
净利率OVBCPLX
| Q4 25 | 24.4% | -60.3% | ||
| Q3 25 | 18.5% | 13.2% | ||
| Q2 25 | 24.2% | 1.0% | ||
| Q1 25 | 26.2% | -35.8% | ||
| Q4 24 | 14.8% | 35.6% | ||
| Q3 24 | 17.6% | 18.0% | ||
| Q2 24 | 20.3% | -16.4% | ||
| Q1 24 | 18.8% | — |
每股收益（稀释后）OVBCPLX
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $45.9M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $170.3M | $48.2M |
| 总资产 | $1.6B | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OVBCPLX
| Q4 25 | $45.9M | $14.7M | ||
| Q3 25 | $89.3M | $13.6M | ||
| Q2 25 | $54.6M | $17.9M | ||
| Q1 25 | $120.6M | $19.5M | ||
| Q4 24 | $83.1M | $19.8M | ||
| Q3 24 | $82.2M | $27.4M | ||
| Q2 24 | $107.7M | $23.4M | ||
| Q1 24 | $129.1M | — |
股东权益OVBCPLX
| Q4 25 | $170.3M | $48.2M | ||
| Q3 25 | $164.4M | $52.9M | ||
| Q2 25 | $160.8M | $49.9M | ||
| Q1 25 | $155.7M | $45.2M | ||
| Q4 24 | $150.3M | $43.2M | ||
| Q3 24 | $152.2M | $32.4M | ||
| Q2 24 | $145.8M | $28.6M | ||
| Q1 24 | $145.8M | — |
总资产OVBCPLX
| Q4 25 | $1.6B | $82.3M | ||
| Q3 25 | $1.6B | $82.3M | ||
| Q2 25 | $1.5B | $78.5M | ||
| Q1 25 | $1.5B | $73.9M | ||
| Q4 24 | $1.5B | $73.4M | ||
| Q3 24 | $1.5B | $61.6M | ||
| Q2 24 | $1.4B | $91.5M | ||
| Q1 24 | $1.4B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.1M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $17.0M | $1.6M |
| 自由现金流率自由现金流/营收 | 105.2% | 17.8% |
| 资本支出强度资本支出/营收 | 6.4% | 4.4% |
| 现金转化率经营现金流/净利润 | 4.57× | — |
| 过去12个月自由现金流最近4个季度 | $26.5M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流OVBCPLX
| Q4 25 | $18.1M | $2.0M | ||
| Q3 25 | $5.3M | $-3.7M | ||
| Q2 25 | $4.5M | $-5.2M | ||
| Q1 25 | $496.0K | $-5.1M | ||
| Q4 24 | $13.1M | $4.0M | ||
| Q3 24 | $5.6M | $4.1M | ||
| Q2 24 | $4.2M | $-3.6M | ||
| Q1 24 | $928.0K | — |
自由现金流OVBCPLX
| Q4 25 | $17.0M | $1.6M | ||
| Q3 25 | $5.0M | $-4.2M | ||
| Q2 25 | $4.4M | $-5.7M | ||
| Q1 25 | $138.0K | $-5.4M | ||
| Q4 24 | $11.7M | $3.6M | ||
| Q3 24 | $5.4M | $4.0M | ||
| Q2 24 | $3.9M | $-3.8M | ||
| Q1 24 | $234.0K | — |
自由现金流率OVBCPLX
| Q4 25 | 105.2% | 17.8% | ||
| Q3 25 | 30.4% | -23.7% | ||
| Q2 25 | 25.1% | -36.2% | ||
| Q1 25 | 0.8% | -53.0% | ||
| Q4 24 | 68.7% | 19.6% | ||
| Q3 24 | 35.1% | 22.4% | ||
| Q2 24 | 26.3% | -28.1% | ||
| Q1 24 | 1.6% | — |
资本支出强度OVBCPLX
| Q4 25 | 6.4% | 4.4% | ||
| Q3 25 | 2.1% | 2.8% | ||
| Q2 25 | 0.6% | 2.8% | ||
| Q1 25 | 2.1% | 3.0% | ||
| Q4 24 | 8.4% | 2.3% | ||
| Q3 24 | 1.2% | 0.5% | ||
| Q2 24 | 2.2% | 1.3% | ||
| Q1 24 | 4.7% | — |
现金转化率OVBCPLX
| Q4 25 | 4.57× | — | ||
| Q3 25 | 1.75× | -1.58× | ||
| Q2 25 | 1.06× | -31.91× | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 5.21× | 0.61× | ||
| Q3 24 | 2.06× | 1.27× | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 0.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OVBC
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
